Retatrutide has emerged as a new pharmaceutical in the fight against obesity. This novel drug, categorized as a dual GLP-1 and GIP receptor agonist, exhibits promising results in research studies. By stimulating https://blakeadym744724.like-blogs.com/35951203/tirzepatide-a-promising-new-treatment-for-obesity